News on Ovarian_Hyperstimulation_Syndrome from BioPortfolio.com http://www.BioPortfolio.com Consolidated Ovarian_Hyperstimulation_Syndrome news from BioPortfolio.com Wed, 10 Feb 2010 03:54:20 GMT en Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988607&HITNO=0&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988607&THISHREF=http://c.moreover.com/click/here.pl%3fz2511263807%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988607&HITNO=0&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988607&THISHREF=http://c.moreover.com/click/here.pl%3fz2511263807%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthcare Sales & Marketing Network: Merck Receives European Approval for ELONVA (corifollitropin alfa injection), a New Fertility ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988370&HITNO=1&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988370&THISHREF=http://c.moreover.com/click/here.pl%3fz2510955416%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988370&HITNO=1&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988370&THISHREF=http://c.moreover.com/click/here.pl%3fz2510955416%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981597&HITNO=2&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981597&THISHREF=http://c.moreover.com/click/here.pl%3fz2507091316%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981597&HITNO=2&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981597&THISHREF=http://c.moreover.com/click/here.pl%3fz2507091316%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comcompaniesandmarkets.com: Merck receives European nod for Elonva for fertility treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980761&HITNO=3&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980761&THISHREF=http://c.moreover.com/click/here.pl%3fz2506571530%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980761&HITNO=3&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980761&THISHREF=http://c.moreover.com/click/here.pl%3fz2506571530%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Merck Receives European Approval for Elonva (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3979696&HITNO=4&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3979696&THISHREF=http://c.moreover.com/click/here.pl%3fz2505921334%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3979696&HITNO=4&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3979696&THISHREF=http://c.moreover.com/click/here.pl%3fz2505921334%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Merck's Follicle Stimulent Elonva Granted European Commission Approval - Updatehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975702&HITNO=5&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975702&THISHREF=http://c.moreover.com/click/here.pl%3fz2504134365%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975702&HITNO=5&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975702&THISHREF=http://c.moreover.com/click/here.pl%3fz2504134365%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRTTNews.com: Merck Receives European Approval for Elonva (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976581&HITNO=6&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976581&THISHREF=http://c.moreover.com/click/here.pl%3fz2504423400%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976581&HITNO=6&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976581&THISHREF=http://c.moreover.com/click/here.pl%3fz2504423400%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974916&HITNO=7&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974916&THISHREF=http://c.moreover.com/click/here.pl%3fz2503798264%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974916&HITNO=7&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974916&THISHREF=http://c.moreover.com/click/here.pl%3fz2503798264%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRed Orbit: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974851&HITNO=8&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974851&THISHREF=http://c.moreover.com/click/here.pl%3fz2503751742%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974851&HITNO=8&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974851&THISHREF=http://c.moreover.com/click/here.pl%3fz2503751742%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Antonio Business Journal: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Trehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974747&HITNO=9&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974747&THISHREF=http://c.moreover.com/click/here.pl%3fz2503692199%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974747&HITNO=9&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974747&THISHREF=http://c.moreover.com/click/here.pl%3fz2503692199%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInterest!ALERT: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974548&HITNO=10&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974548&THISHREF=http://c.moreover.com/click/here.pl%3fz2503576650%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974548&HITNO=10&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974548&THISHREF=http://c.moreover.com/click/here.pl%3fz2503576650%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHouston Chronicle: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a Newhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974463&HITNO=11&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974463&THISHREF=http://c.moreover.com/click/here.pl%3fz2503527088%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974463&HITNO=11&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974463&THISHREF=http://c.moreover.com/click/here.pl%3fz2503527088%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comForbes.com: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974443&HITNO=12&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974443&THISHREF=http://c.moreover.com/click/here.pl%3fz2503508522%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974443&HITNO=12&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974443&THISHREF=http://c.moreover.com/click/here.pl%3fz2503508522%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974413&HITNO=13&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974413&THISHREF=http://c.moreover.com/click/here.pl%3fz2503479146%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974413&HITNO=13&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974413&THISHREF=http://c.moreover.com/click/here.pl%3fz2503479146%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974412&HITNO=14&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974412&THISHREF=http://c.moreover.com/click/here.pl%3fz2503477861%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974412&HITNO=14&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ovarian_Hyperstimulation_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974412&THISHREF=http://c.moreover.com/click/here.pl%3fz2503477861%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: